What researchers published on Mezotelióma
6203 papers, newest first.
Showing 40 of 6203
RETRACTED: Ramundo et al. APE-1/Ref-1 Inhibition Blocks Malignant Pleural Mesothelioma Cell Proliferation and Migration: Crosstalk Between Oxidative Stress and Epithelial Mesenchymal Transition (EMT) in Driving Carcinogenesis and Metastasis. Int. J. Mol. Sci. 2023, 24, 12570.International journal of molecular sciences
Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma.Cureus
The Sibaté Asbestos-Cement Facility Case Study: Reconstructing the Production Process to Assess Occupational and Environmental Impacts.Annals of global health
ÁttekintésReview of Registries, Databases and Biobanks for Surveillance and Research on Mesothelioma.Cancers
ÁttekintésBeyond Mesothelioma: From Diagnostic Biomarker to Therapeutic Opportunity-The Emerging Role of MTAP in Cancer.International journal of molecular sciences
Real-World Outcomes of Oral VEGFR Tyrosine Kinase Inhibitor-Containing Therapy in Unresectable Malignant Mesothelioma: A Single-Center Retrospective Study.Cancers
Correction: Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
Recent advances in the treatment of pleural mesothelioma.Current opinion in oncology
Targeting the CCL5-CCR5 axis protects against chemoresistant mesothelioma development through macrophage reprogramming.Cancer letters
High-Pressure/High-Dose Versus Standard PIPAC in Epithelioid Peritoneal Mesothelioma: Safety, Feasibility, and Outcomes From a Bicentric Comparative Cohort Study.Annals of surgical oncology
Evolution and distribution of malignant pleural mesothelioma mortality in Spain: 2016-2022.Pulmonology
Outcomes of Platinum plus /Pemetrexed Rechallenge in Pleural Mesothelioma: The Role of Platinum-Free Interval in a Multicenter Real-World Analysis.JTO clinical and research reports
Multiomics Analysis of Malignant Pleural Mesothelioma Reveals the Immunological Microenvironment Associated with MTAP Loss and Immunotherapy Outcomes.Clinical cancer research : an official journal of the American Association for Cancer Research
[Current State of the Asbestos Outpatient Clinic and an Evaluation of Asbestos Bodies].Kyobu geka. The Japanese journal of thoracic surgery
Esetismertetés[Surgical Case of Primary Malignant Pericardial Mesothelioma].Kyobu geka. The Japanese journal of thoracic surgery
USP14 promotes malignant pleural mesothelioma progression and suppresses autophagy by stabilizing the YAP1-TEAD4 axis.Molecular biology reports
ÁttekintésCross-lineage mesenchymal transition in mesothelioma.Cancer metastasis reviews
Prognostic factors after multimodality treatment for pleural mesothelioma.Interdisciplinary cardiovascular and thoracic surgery
Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia.Frontiers in oncology
Multimodality imaging in the diagnosis and staging of malignant pleural mesothelioma.BMJ case reports
Anti-Ma1/Ma2 paraneoplastic neurological syndrome associated with malignant mesothelioma: a case study.BMJ neurology open
Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.Frontiers in genetics
Post-Recurrence Treatment Patterns and Outcomes After Curative-Intent Multimodality Strategy in Patients with Pleural Mesothelioma: A Retrospective Cohort Study.Journal of clinical medicine
Prognostic Significance of B7-H3, TROP2, and p16 Expression in Pleural Mesothelioma: Clinicopathological Correlations and Survival Outcomes.Journal of clinical medicine
Treatment-specific Association of H&E-based Stromal Tumor-infiltrating Lymphocytes With Survival in Pleural Mesothelioma Treated With Ipilimumab/Nivolumab or Chemotherapy.Anticancer research
ÁttekintésMTAP Loss and Pleural Mesothelioma (PM): Current Treatment Strategies and Emerging Therapeutic Approaches.Cancers
Correction: Strategic selection of MDM2 inhibitors enhances the efficacy of FAK inhibition in mesothelioma based on TP53 genotype.PloS one
Integrative Bioinformatics and Machine Learning Approaches for Biomarker and Pathway Discovery in Malignant Pleural Mesothelioma.Cancer reports (Hoboken, N.J.)
HMGB1 directly activates BAP1 transcription to sustain tumor growth in mesothelioma.Cell death and differentiation
ÁttekintésReprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity.Frontiers in immunology
EsetismertetésUltrasonic manifestations of diffuse pericardial mesothelioma masquerading as pericardial effusion: a case report.Frontiers in oncology
When art anticipates disease: asbestos, conceptual painting and mesothelioma.Medical humanities
Randomised pilot and feasibility study comparing video-assisted thoracoscopic partial pleurectomy-decortication with indwelling pleural catheter for trapped lung in pleural mesothelioma.Thorax
Beyond the pleura: National trends in mesothelioma mortality by anatomical site in Spain, 1999-2024.Cancer epidemiology
Hexokinase II as a Potential Target of Apigenin Through the Induction of Apoptosis and Necroptosis in Malignant Mesothelioma.Nutrients
Awareness of Partial Loss is Essential in Interpreting Merlin Immunohistochemistry When Diagnosing Pleural Mesothelioma.Pathology international
EsetismertetésNephrotic Syndrome During Ipilimumab Plus Nivolumab Therapy for Sarcomatoid Malignant Pleural Mesothelioma: A Case Report of Nivolumab Rechallenge Without Recurrence of Nephrotic Syndrome.Cureus
EsetismertetésPleural Mesothelioma With Unusual Squamous Differentiation: A Clinicopathological Case Report With Molecular Insights From Whole-Exome Sequencing.Pathology international
Correction: Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.Oncogene
FANCD2 knockdown suppresses malignant phenotypes and is associated with caspase/PARP-mediated apoptosis in NCI-H2052 pleural mesothelioma cells.Frontiers in genetics